TrialThe Journal of clinical investigation2021

Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial.

Suzanne L Campion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.